We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: INDs and Clinical Protocols Require Registry Certification
FDA: INDs and Clinical Protocols Require Registry Certification
January 21, 2009
Drugmakers submitting INDs with new clinical trial protocols are advised to certify to the FDA that they have met all requirements of the clinical trial database registry law, according to a final guidance.